Bailong Chuangyuan(SH:605016) Xin Lang Cai Jing·2026-01-07 02:40Group 1 - The core point of the news is that Shandong Bailong Chuangyuan Biotechnology Co., Ltd. experienced a 5.16% drop in stock price, closing at 20.95 CNY per share, with a total market capitalization of 8.799 billion CNY [1] - The company was established on December 30, 2005, and went public on April 21, 2021. Its main business involves the research, production, and sales of prebiotic products, dietary fiber products, other starch sugar (alcohol) products, and health sweeteners [1] - The revenue composition of the company's main business includes dietary fiber series (54.15%), prebiotic series (28.00%), health sweeteners (13.57%), other (supplement) (3.91%), and other starch sugar (alcohol) (0.38%) [1] Group 2 - From the perspective of the top ten circulating shareholders, Baodao Fund's Baodao Huitai Optimal Mixed A (016840) increased its holdings by 121,900 shares in the third quarter, holding a total of 4.8799 million shares, which accounts for 1.16% of the circulating shares [2] - The fund has a current scale of 778 million CNY and has achieved a year-to-date return of 2.19%, ranking 5543 out of 8823 in its category, while its one-year return is 31.74%, ranking 3977 out of 8083 [2] Group 3 - The fund manager of Baodao Huitai Optimal Mixed A (016840) is Sun Wenlong, who has a cumulative tenure of 10 years and 353 days, with the fund's total asset scale at 2.244 billion CNY [3] - During his tenure, the best fund return was 238.74%, while the worst return was -2.98% [3] Group 4 - Baodao Huitai Optimal Mixed A (016840) is one of the top holdings in the Baodao Fund, with 4.36% of the fund's net value allocated to Bailong Chuangyuan, making it the fourth-largest holding [4] - The estimated floating loss for the fund today is approximately 5.5631 million CNY [4]